What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
Launched by UNIVERSITY OF MICHIGAN · Nov 19, 2013
Trial Information
Current as of October 22, 2025
Completed
Keywords
ClinConnect Summary
Currently benign conditions of the uterus are frequently underdiagnosed or misdiagnosed. This project will help determine which diagnostic radiology exams are most helpful to the clinician in providing accurate diagnosis. In addition, this study will evaluate which exam (MRI vs. Ultrasound) patients prefer over another exam.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years of age or older
- • 2. Pelvic pain and/or abnormal uterine bleeding. (this is specific for Arm. 1 of this study)
- • 3. If you have had or are scheduled to have both a pelvic MRI (magnetic resonance imaging) and a pelvic ultrasound with 6 months of the time of enrollment. (this is specific to Arm 2 of this study).
- • -
- Exclusion Criteria:
- • 1. If you are post-menopausal(have not had a period in at least one year's time).
- • 2. If you have been diagnosed with gynecological malignancy such as uterine, endometrial, cervical or ovarian cancer.
- • 3. If you are unable or unwilling to sign the informed consents
- • 4. If you are unable to undergo the research study exams -
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Katherine Maturen, MD, MS
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials